Education and Training
Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention
A multi-center, randomized controlled 2-arm trial comparing the effectiveness of an innovative shared decision-making pathway and usual care for Atrial Fibrillation Stroke Prevention
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- behavioral: SDMT
- behavioral: Usual Care
Eligibility
Inclusion Criteria:
- ≥ 18 y/o
- Non-valvular atrial fibrillation or atrial flutter (AFib)
- CHA2DS2-VASc stroke score of:
- Men: 1 or more
- Women: 2 or more
- Able to consent in English or Spanish (if resources allow) and follow study
instructions
Exclusion Criteria:
- Moderate to severe mitral stenosis
- Mechanical valve replacement
- Absolute contraindication to anticoagulation (Based on clinician judgment)
- Indication for anticoagulation therapy for a condition other than atrial fibrillation
- Left atrial appendage exclusion (by surgery or device placement)
- At the clinical discretion of the investigator
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Katie DeSutter
650-725-4151
Not Recruiting